Brief: Atara Biotherapeutics Announces Expanded Global Tab-Cel Partnership With Pierre Fabre Laboratories

Atara Biotherapeutics

01/11/2023 13:52

Nov 1 (Reuters) - Atara Biotherapeutics Inc  ATRA.O :
    * ATARA BIOTHERAPEUTICS ANNOUNCES EXPANDED GLOBAL TAB-CEL®
PARTNERSHIP WITH PIERRE FABRE LABORATORIES AND THIRD QUARTER
2023 FINANCIAL RESULTS
    * ATARA BIOTHERAPEUTICS INC: QTRLY EARNINGS PER SHARE $0.66
    * ATARA BIOTHERAPEUTICS INC: CASH, CASH EQUIVALENTS AND
SHORT-TERM
INVESTMENTS AS OF SEPTEMBER 30, 2023, TOTALED $102.4 MILLION
    * ATARA BIOTHERAPEUTICS INC: ATARA TO RECEIVE ADDITIONAL
PAYMENTS
OF UP TO USD 640 MILLION
    * ATARA BIOTHERAPEUTICS INC: EXPECTS TO SUBMIT TAB-CEL
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE (PTLD) BLA IN Q2
2024
    * ATARA BIOTHERAPEUTICS INC: QTRLY TOTAL REVENUE $2.1
MILLION
VERSUS $4.5 MILLION
    * ATARA BIOTHERAPEUTICS INC: TAB-CEL GLOBAL PARTNERSHIP AND
ASSOCIATED STRATEGIC RESTRUCTURING EXTENDS ATARA CASH RUNWAY
INTO Q3 2025

Source text for Eikon:  ID:nBw8jtLJJa 
Further company coverage:  ATRA.O